Nervonik

Stub active Updated Apr 29, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location Los Angeles, CA
Founded 2019
Latest Stage Series B
Total Raised $52.5M+
Sector
medtech neurology neuromodulation healthcare deeptech

About

Nervonik is a Los Angeles-based medical device company developing peripheral nerve stimulation (PNS) technology for chronic pain treatment 12. The platform applies controlled electrical currents to peripheral nerves through leads connected to miniaturized implantable pulse generators (IPGs), powered by a small programmable wearable device 1. The April 2026 oversubscribed Series B funds continued development and commercialization of the PNS system, including proprietary sensing capabilities 1.

Funding History

Date Round Amount Lead Co-investors
2026-04-27 Series B $52.5M Amzak Health Elevage Medical Technologies, U.S. Venture Partners (USVP), Lumira Ventures, Foothill Ventures, Shangbay Capital 12

What Investors Say

No independently sourced investor quotes found.

What Founders Say

No independently sourced founder quotes found.

Sources

  1. PR Newswire, “Nervonik Announces $52.5 Million Series B Financing to Advance Peripheral Nerve Stimulation Therapy,” April 27, 2026. https://www.prnewswire.com/news-releases/nervonik-announces-52-5-million-series-b-financing-to-advance-peripheral-nerve-stimulation-therapy-302753428.html↩↩↩↩

  2. MassDevice, “Nervonik closes $52.5M Series B for peripheral nerve stim tech,” April 27, 2026. https://www.massdevice.com/nervonik-closes-52m-series-b/↩↩